006280 — GC Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩2tn
- KR₩2tn
Annual cashflow statement for GC Biopharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11,287 | 89,271 | 136,950 | 69,415 | -19,809 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 63,631 | -2,981 | -21,276 | 47,204 | 79,765 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -58,719 | -99,107 | -45,599 | -62,561 | -141,328 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 40,291 | 35,974 | 125,979 | 119,154 | -5,473 |
| Capital Expenditures | -147,617 | -101,395 | -123,539 | -94,690 | -125,992 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -30,293 | 131,079 | -8,539 | -110,569 | -24,252 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -177,910 | 29,684 | -132,077 | -205,259 | -150,243 |
| Financing Cash Flow Items | 84,070 | 11,325 | -42,611 | 146 | 1,308 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 140,805 | 80,987 | -41,270 | -2,481 | 100,512 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,826 | 133,827 | -46,228 | -80,694 | -55,660 |